AMERICAN BIOSCIENCE LICENSES ABRAXANE(TM) TO TAIHO PHARMACEUTICAL CO., LTD.

A A

American BioScience, Inc. (ABI) today announced it has licensed ABRAXANE(TM) to Taiho Pharmaceutical Co., Ltd., (Taiho) and established a Joint Steering Committee with Taiho which will oversee the development of ABRAXANE in Japan for the treatment of breast, lung, gastric, and other solid tumors. ABRAXANE is being commercialized in North America by Abraxis(TM) Oncology, a division of American Pharmaceutical Partners, Inc. (NASDAQ: APPX) .

PR Newswire (http://sev.prnewswire.com/health-care-hospitals/20051115/LATU18616112005-1.html)